Kimia Farma Valuation
| KAEF Stock | IDR 635.00 5.00 0.78% |
At this time, the firm appears to be overvalued. Kimia Farma Persero secures a last-minute Real Value of 547.76 per share. The latest price of the firm is 635.0. Our model forecasts the value of Kimia Farma Persero from analyzing the firm fundamentals such as Profit Margin of (0.02) %, return on equity of -0.026, and Current Valuation of 14.62 T as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Kimia Farma's price fluctuation is very steady at this time. Calculation of the real value of Kimia Farma Persero is based on 3 months time horizon. Increasing Kimia Farma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Kimia Farma's intrinsic value may or may not be the same as its current market price of 635.00, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 635.0 | Real 547.76 | Hype 635.0 | Naive 654.44 |
The intrinsic value of Kimia Farma's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Kimia Farma's stock price.
Estimating the potential upside or downside of Kimia Farma Persero helps investors to forecast how Kimia stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Kimia Farma more accurately as focusing exclusively on Kimia Farma's fundamentals will not take into account other important factors: Kimia Farma Total Value Analysis
Kimia Farma Persero is now forecasted to have takeover price of 14.62 T with market capitalization of 5.78 T, debt of 3.25 T, and cash on hands of (1.54 B). Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Kimia Farma fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
14.62 T | 5.78 T | 3.25 T | (1.54 B) |
Kimia Farma Investor Information
About 96.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.9. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Kimia Farma Persero recorded earning per share (EPS) of 7.09. The entity last dividend was issued on the 23rd of May 2022. Based on the key measurements obtained from Kimia Farma's financial statements, Kimia Farma Persero is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Kimia Farma Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of Kimia suggests not a very effective usage of assets in December.Kimia Farma Ownership Allocation
Kimia Farma Persero maintains a total of 5.55 Billion outstanding shares. Kimia Farma Persero secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 95.8 % of Kimia Farma Persero outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Kimia Farma Profitability Analysis
The company reported the revenue of 12.86 T. Net Income was 302.27 B with profit before overhead, payroll, taxes, and interest of 4.05 T.About Kimia Farma Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Kimia Farma Persero. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Kimia Farma Persero based exclusively on its fundamental and basic technical indicators. By analyzing Kimia Farma's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Kimia Farma's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Kimia Farma. We calculate exposure to Kimia Farma's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Kimia Farma's related companies.PT Kimia Farma Tbk produces and sells medicines, herbal medicines, iodine, salts, quinine and their derivative products, and vegetable oils in Indonesia, rest of Asia, Europe, Australia, Africa, and New Zealand. The company was founded in 1817 and is headquartered in Jakarta, Indonesia. Kimia Farma operates under Drug ManufacturersSpecialty Generic classification in Indonesia and is traded on Jakarta Stock Exchange. It employs 11772 people.
8 Steps to conduct Kimia Farma's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Kimia Farma's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Kimia Farma's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Kimia Farma's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Kimia Farma's revenue streams: Identify Kimia Farma's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Kimia Farma's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Kimia Farma's growth potential: Evaluate Kimia Farma's management, business model, and growth potential.
- Determine Kimia Farma's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Kimia Farma's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Other Information on Investing in Kimia Stock
Kimia Farma financial ratios help investors to determine whether Kimia Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kimia with respect to the benefits of owning Kimia Farma security.